• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Immunity to COVID in Britain is waning as winter looms, testing expert warns, and there’s no plan for a wide-scale booster program in sight

By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
August 11, 2022, 8:42 AM ET
The image shows a British nurse in full PPE preparing a COVID vaccine.
The U.K. findings come after America’s top doctor, Anthony Fauci, warned anyone who isn’t up to date with their COVID vaccinations is soon “going to get into trouble.” Jeff J Mitchell—Pool/Getty Images

Rates of high antibody protection are declining in the U.K., prompting warnings that the population will have insufficient immunity levels as it heads into the “dangerous” winter months.

Published Wednesday, new figures from Britain’s Office for National Statistics (ONS) revealed that the number of people with a high level of antibodies against the virus was rapidly dwindling.

Anything above 800 nanograms (ng) of antibodies per milliliter of blood is considered a high level, according to the ONS.

The organization’s latest data revealed that 71.7% of the English population had this high level of antibodies between July 11 and July 17—marking a 1.4% decline from a week earlier.

The data included samples from 10,234 people over the age of 16 living in England.

The picture was similar across Britain, with high antibody rates also declining in Scotland, Wales, and Northern Ireland.

The ONS research dates back to December 2020, when it found that just 0.7% of English adults had high antibody levels.

High antibody levels peaked in March this year, according to the data, when 82% of England’s population had high antibody protection.

Wednesday’s data marked a 12% decline from the March peak in high antibody levels across England.

The ONS noted on Wednesday that its methodology for the study changed in May. However, the trend in the data continued as before.

Meanwhile, the data showed that the U.K.’s baseline antibody level of at least 179 ng per ml of blood—which had been set at the height of the Delta wave of the pandemic—had held firm, with the proportion of the population with this level of antibodies remaining unchanged from a week earlier and showing little change from mid-March.

‘Dangerous’ times ahead

The U.K. was the first country in the world to administer doses of coronavirus vaccines outside of clinical trials in December 2020, and the peak in high antibody levels seen in March came after the country’s booster program was rolled out to all adults.

People over the age of 75 and those with weakened immune systems became eligible for a second booster dose in the spring of this year.

A total of 87.9% of people in the U.K. over the age of 12 have received two doses of a COVID vaccine. Seven in 10 have had a booster shot.

While there are plans for an autumn booster program for certain individuals in Britain, including the over-fifties, frontline health care workers, and the immunosuppressed, no plans have been announced to extend the additional booster doses to the wider population.

A spokesperson for the U.K. government was not immediately available for comment when contacted by Fortune.

Dr. Quinton Fivelman, lead testing expert and chief scientific officer at London Medical Laboratory, said in a press release on Thursday that populations needed to retain a substantial number of antibodies as they entered “the dangerous winter months.”

“This dramatic 12.7% decrease in the number of people in England with a significant number of antibodies to COVID is obviously concerning,” he said.

Fivelman added that less than 70% of people in Britain were now likely to have high levels of antibody protection against COVID-19.

“The simple truth is that, if this rate of decline continues to accelerate and the first U.K. adults don’t start receiving their boosters until October, only 60% of the population will retain substantial antibodies by the time they are jabbed,” he warned.

Fivelman told Fortune that London Medical Laboratory’s research indicated vaccine-derived immunity waned substantially once three months had passed since vaccination. This was true regardless of which vaccine an individual received, he added.

“One developing concern is that the new Omicron BA.4 and BA.5 subvariants do not produce as high an immune response as the previous strains, so reinfection is more likely to occur,” he said. “Higher levels of antibodies are important to neutralize the virus, stopping infection and limiting people transmitting the virus to others.”

Fivelman’s comments echo a warning from America’s top doctor Anthony Fauci last week that anyone who was not up to date with their COVID vaccinations heading into the fall and winter months was “going to get into trouble.”

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Chloe Taylor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By Eleanor PringleFebruary 4, 2026
1 day ago
placeholder alt text
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the board
By Jim EdwardsFebruary 4, 2026
1 day ago
placeholder alt text
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving example
By Nick LichtenbergFebruary 4, 2026
20 hours ago
placeholder alt text
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'
By Emma BurleighFebruary 3, 2026
2 days ago
placeholder alt text
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By Emma BurleighFebruary 2, 2026
3 days ago
placeholder alt text
North America
Gates Foundation doubles down on foreign aid as U.S. government largely withdraws
By Thalia Beaty and The Associated PressFebruary 3, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

HealthDietary Supplements
The 6 Best Prebiotics of 2026: Tester Approved
By Christina SnyderFebruary 4, 2026
18 hours ago
Healthsleep
The Best Cooling Sheets of 2026: Personally Tested
By Christina SnyderFebruary 4, 2026
18 hours ago
A person sleeping in bed.
Healthsleep
What Is the Best Sleeping Position?
By Jessica RendallFebruary 4, 2026
22 hours ago
C-Suitesubscription economy
The CEO of $11 billion Oura explains why customers must shell out for subscription fees after paying $349 or more for the ring
By Marco Quiroz-GutierrezFebruary 4, 2026
23 hours ago
Healthsleep
7 Best Mattresses for Stomach Sleepers of 2026: Sleep Expert Tested
By Christina SnyderFebruary 4, 2026
1 day ago
SuccessOlympics
U.S. Olympians earn just 5% of what Singapore pays—many are forced to juggle jobs as baristas, brokers, and dentists just to get by
By Sydney LakeFebruary 3, 2026
2 days ago